• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Optimal use of bisphosphonates in patients with multiple myeloma.

作者信息

Terpos Evangelos, Roodman G David, Dimopoulos Meletios A

机构信息

Department of Clinical Therapeutics, University of Athens School of Medicine, Athens,

出版信息

Blood. 2013 Apr 25;121(17):3325-8. doi: 10.1182/blood-2012-10-435750. Epub 2013 Feb 13.

DOI:10.1182/blood-2012-10-435750
PMID:23407550
Abstract
摘要

相似文献

1
Optimal use of bisphosphonates in patients with multiple myeloma.双膦酸盐在多发性骨髓瘤患者中的最佳应用
Blood. 2013 Apr 25;121(17):3325-8. doi: 10.1182/blood-2012-10-435750. Epub 2013 Feb 13.
2
[Integrated supportive therapy for multiple myeloma-bone disease treatment, myeloma kidney treatment, cryotherapy, nutrition support team].[多发性骨髓瘤骨病治疗、骨髓瘤肾病治疗、冷冻疗法、营养支持团队的综合支持治疗]
Nihon Rinsho. 2012 Apr;70 Suppl 2:603-27.
3
Bisphosphonate therapy in the treatment of multiple myeloma.双膦酸盐治疗多发性骨髓瘤。
Curr Pharm Des. 2010;16(27):3028-36. doi: 10.2174/138161210793563608.
4
Serum C terminal telopeptide maintains its correlation with bone disease in patients with myeloma even under treatment with bisphosphonates.即使在接受双膦酸盐治疗的情况下，血清C端肽在骨髓瘤患者中仍与骨病保持相关性。
Leuk Lymphoma. 2014 Jun;55(6):1397-8. doi: 10.3109/10428194.2013.830305. Epub 2013 Sep 3.
5
Novel therapeutic targets in myeloma bone disease.骨髓瘤骨病中的新型治疗靶点。
Br J Pharmacol. 2014 Aug;171(16):3765-76. doi: 10.1111/bph.12742.
6
Therapeutic role of bisphosphonate and radiation combination in the management of myeloma bone disease.双膦酸盐与放疗联合治疗在骨髓瘤骨病管理中的作用
Clin Cancer Res. 2007 Jun 1;13(11):3432. doi: 10.1158/1078-0432.CCR-07-0079.
7
Denosumab for the treatment of bone disease in solid tumors and multiple myeloma.地舒单抗治疗实体瘤和多发性骨髓瘤的骨骼疾病。
Future Oncol. 2018 Feb;14(3):195-203. doi: 10.2217/fon-2017-0403. Epub 2017 Oct 20.
8
Challenging the current approaches to multiple myeloma- and other cancer-related bone diseases: from bisphosphonates to targeted therapy.挑战多发性骨髓瘤和其他癌症相关骨骼疾病的现行方法：从双磷酸盐类药物到靶向治疗。
Leuk Lymphoma. 2012 Jun;53(6):1057-61. doi: 10.3109/10428194.2011.644548. Epub 2012 Jan 13.
9
[Guidelines for the use of bisphosphonates in multiple myeloma: Recommendations of the expert committee of the Spanish Myeloma Group from the PETHEMA group].[多发性骨髓瘤中双膦酸盐的使用指南：来自PETHEMA组的西班牙骨髓瘤小组专家委员会的建议]
Med Clin (Barc). 2010 Mar 6;134(6):268-78. doi: 10.1016/j.medcli.2009.07.040. Epub 2009 Oct 28.
10
Denosumab for bone lesions in multiple myeloma - what is its value?地诺单抗用于多发性骨髓瘤骨病变——其价值何在？
Haematologica. 2018 May;103(5):753-754. doi: 10.3324/haematol.2017.185264.

引用本文的文献

1
Cystatin M/E Ameliorates Multiple Myeloma-Induced Hyper Osteolytic Bone Resorption.胱抑素M/E可改善多发性骨髓瘤诱导的高溶骨性骨吸收。
Cancers (Basel). 2025 Feb 27;17(5):833. doi: 10.3390/cancers17050833.
2
Cystatin M/E ameliorates bone resorption through increasing osteoclastic cell estrogen influx.胱抑素M/E通过增加破骨细胞雌激素内流来改善骨吸收。
Res Sq. 2024 May 6:rs.3.rs-4313179. doi: 10.21203/rs.3.rs-4313179/v1.
3
Multiple Myeloma Bone Disease: Implication of MicroRNAs in Its Molecular Background.多发性骨髓瘤骨病：微小 RNA 在其分子背景中的作用。
Int J Mol Sci. 2021 Feb 27;22(5):2375. doi: 10.3390/ijms22052375.
4
Keeping an Eye on Bisphosphonate Therapy in Myeloma: A Case Report of Ocular Inflammation Postzoledronic Acid Infusion.关注骨髓瘤中的双膦酸盐治疗：一例唑来膦酸输注后眼部炎症的病例报告。
Case Rep Hematol. 2021 Feb 13;2021:6647277. doi: 10.1155/2021/6647277. eCollection 2021.
5
Use of bisphosphonates in multiple myeloma patients in Denmark, 2005-2015.丹麦 2005-2015 年多发性骨髓瘤患者双磷酸盐的使用情况。
Support Care Cancer. 2021 Aug;29(8):4501-4511. doi: 10.1007/s00520-020-05934-8. Epub 2021 Jan 18.
6
Racial Disparities in Intravenous Bisphosphonate Use Among Older Patients With Multiple Myeloma Enrolled in Medicare.医疗保险中多发性骨髓瘤老年患者静脉用双膦酸盐使用的种族差异。
JCO Oncol Pract. 2021 Mar;17(3):e294-e312. doi: 10.1200/OP.20.00479. Epub 2021 Jan 15.
7
Dental implant in a multiple myeloma patient undergoing bisphosphonate therapy: A case report.一名接受双膦酸盐治疗的多发性骨髓瘤患者的牙种植体：病例报告。
Clin Case Rep. 2019 Apr 16;7(5):1043-1048. doi: 10.1002/ccr3.2150. eCollection 2019 May.
8
Use of Bisphosphonates in Elderly Patients With Newly Diagnosed Multiple Myeloma.在新诊断多发性骨髓瘤的老年患者中使用双膦酸盐。
J Natl Compr Canc Netw. 2019 Jan;17(1):22-28. doi: 10.6004/jnccn.2018.7079.
9
Bone-targeted agents in multiple myeloma.多发性骨髓瘤中的骨靶向药物。
Hematol Rep. 2018 Mar 29;10(1):7401. doi: 10.4081/hr.2018.7401. eCollection 2018 Mar 2.
10
Pathogenesis of bone disease in multiple myeloma: from bench to bedside.多发性骨髓瘤中骨病的发病机制：从基础到临床。
Blood Cancer J. 2018 Jan 12;8(1):7. doi: 10.1038/s41408-017-0037-4.